AbbVie Inc. (ETR:4AB)
201.50
+0.50 (0.25%)
Oct 10, 2025, 5:35 PM CET
AbbVie Revenue
AbbVie had revenue of $15.42B USD in the quarter ending June 30, 2025, with 6.65% growth. This brings the company's revenue in the last twelve months to $58.33B, up 6.05% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$58.33B
Revenue Growth
+6.05%
P/S Ratio
7.05
Revenue / Employee
$1.06M
Employees
55,000
Market Cap
350.31B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | 33.27B | 513.00M | 1.57% |
Dec 31, 2018 | 32.75B | 4.54B | 16.08% |
Dec 31, 2017 | 28.22B | 2.58B | 10.06% |
Dec 31, 2016 | 25.64B | 2.78B | 12.16% |
Dec 31, 2015 | 22.86B | 2.90B | 14.52% |
Dec 31, 2014 | 19.96B | 1.17B | 6.23% |
Dec 31, 2013 | 18.79B | 410.00M | 2.23% |
Dec 31, 2012 | 18.38B | 936.00M | 5.37% |
Dec 31, 2011 | 17.44B | 1.81B | 11.55% |
Dec 31, 2010 | 15.64B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
AbbVie News
- 1 day ago - Piper Sandler Raises Price Target for AbbVie (ABBV) to $284, Maintains Overweight Rating | ABBV ... - GuruFocus
- 1 day ago - Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? - Nasdaq
- 2 days ago - Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing - The Motley Fool
- 2 days ago - See Which Of The Latest 13F Filers Holds ABBV - Nasdaq
- 2 days ago - AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025? - Nasdaq
- 2 days ago - SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst Moisturizer - PRNewsWire
- 2 days ago - How pharma giant AbbVie holds leaders accountable for culture - Fortune
- 3 days ago - A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know - Benzinga